Overview

Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:
0

Participant gender:
All

Summary

All patients with acute aneurysmal hemorrhage are treated in accordance with our institutional protocol. After securing of the aneurysm, some smokers with acute aneurysmal hemorrhage are randomly assigned to transdermal nicotine replacement (NRT). The short- and long-term effect of NRT will be studied comparing non-smokers, smokers without NRT and smokers with NRT.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Oslo University Hospital

Treatments:

Nicotine

Criteria

Inclusion Criteria:

- aneurysmal subarachnoid hemorrhage after securing of the aneurysm and surviving the
first 2 weeks.

Exclusion Criteria:

- manifest cerebral vasospasm at arrival at our department (i.e. before securing of the
aneurysm)